11.11.2009 • News

Huntsman Q2 Profit Skyrockets

Huntsman said its second-quarter profit skyrocketed as a hefty legal settlement offset a steep drop in sales. For the period ended June 30, the company reported net income of $406 million compared with $24 million in the year-earlier period. The results were bolstered by a gain of $1.7 billion from a settlement earlier in the year with Deutsche Bank and Credit Suisse Group. Sales fell 36 % to $1.87 billion.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

most read